The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

Looking to give your skincare regimen a makeover this summer? We've got you covered. We're helping you beat out the heat, ...

A game-changer for dry eyes? - Screen overexposure left my eyes tired and sore, but Peep Club’s soothing wand has restored ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

Objective: To evaluate the immediate effectiveness of intense regulated pulsed light applied to the periocular area of patients with dry eyes in a retrospective study ... applied to the periocular ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).